Dein Bonus wartet – Hol Dir jetzt Dein finanzen.net ZERO-Depot und handle ohne Ordergebühr (zzgl. Spreads).

Franklin Covey (FC) Soars 5.7%: Is Further Upside Left in the Stock?

29.09.25 13:47 Uhr

Werte in diesem Artikel
Aktien

17,16 USD -0,77 USD -4,29%

Franklin Covey (FC) shares rallied 5.7% in the last trading session to close at $20.19. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3% loss over the past four weeks.The rise appears to be largely a technical bounce following a prolonged downturn. After an extended period of weakness, investors may be seizing the opportunity to enter at attractive levels, triggering short-term buying momentum.This corporate training and consultanting company is expected to post quarterly earnings of $0.43 per share in its upcoming report, which represents a year-over-year change of -51.7%. Revenues are expected to be $70.97 million, down 15.6% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Franklin Covey, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FC going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Franklin Covey is part of the Zacks Consulting Services industry. Exponent (EXPO), another stock in the same industry, closed the last trading session 0.3% higher at $69.5. EXPO has returned -4% in the past month.Exponent's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.5. Compared to the company's year-ago EPS, this represents no change. Exponent currently boasts a Zacks Rank of #2 (Buy).5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Franklin Covey Company (FC): Free Stock Analysis Report Exponent, Inc. (EXPO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Franklin Covey

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Franklin Covey

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Franklin Covey CoShs

Wer­bung

Analysen zu Franklin Covey CoShs

DatumRatingAnalyst
09.01.2018Franklin Covey OutperformBarrington Research
28.12.2016Franklin Covey Mkt PerformBarrington Research
05.11.2015Franklin Covey BuyROTH Capital Partners, LLC
02.07.2015Franklin Covey BuyROTH Capital Partners, LLC
DatumRatingAnalyst
09.01.2018Franklin Covey OutperformBarrington Research
05.11.2015Franklin Covey BuyROTH Capital Partners, LLC
02.07.2015Franklin Covey BuyROTH Capital Partners, LLC
DatumRatingAnalyst
28.12.2016Franklin Covey Mkt PerformBarrington Research
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Franklin Covey CoShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen